381
·
10-19 23:42
I closed $NIO 20241018 9.0 CALL$ ,NIO: collected full premium from these covered calls when it expired worthless on 18th Oct. Sold at the height of Chinese market rally so the strike was set at $9 and still get decent premiums. Price had since retreated back to $5.22 now.
3.77K
·
10-20 21:42
US Market: A Record-Breaking Week 21st Oct ?
On Fri, 18 Oct 2024 - both Dow Jones & the S&P 500 surged to new record highs, sealing six straight weeks of gains. Closing Time. When US market officially closed at 4pm: DJIA: +0.09% (+36.86 to 43,275.91). S&P 500: +0.40% (+23.20 to 5,864.67). Nasdaq: +0.63% (+115.94 to 18,489.55). The three major averages cinched their 6th straight positive week. This also marked the longest string of weekly advances in 2024 for both the Dow and S&P 500, which respectively ended +0.96% and +0.85% higher. The Nasdaq climbed +0.80%. Main Catalysts. Two main catalysts helped US market to chart new highs. They were: $Netflix(NFLX)$ . Bank stocks. Streaming Media Giant. Prior to Netflix’s (FAANG’s) earnings release, I have a 14 Oct 2024 post
TOPJC888: Hi, tks for reading my post. I make time to write & share. Pls "Re-post" so that more get to know. Tks! Rating is important (to me). Consider "Follow me" and get first hand read of my Daily new posts? Thanks!). Tks!!
164
·
10-20 23:06
Is the banking sector coping well?
Is the banking sector coping well? Auto loan serious delinquencies of 90+ days spiked to 2.88%, the most since 2Q 2010. They are rising at a similar pace to the one seen in the 2008 Financial Crisis. Meanwhile, Auto loan debt hit a record $1.6 trillion. - X user Global Markets Investor JPMorgan Chase, Bank of America, Wells Fargo and Citi recorded $6.9 billion in net charge-offs in Q3 of this year, primarily driven by credit card delinquencies and soured consumer loans. How about the regional banks? - DailyHodl UNREALISED LOSSES BY U.S. BANKS 7x HIGHER THAN 2008 FINANCIAL CRISIS With the above news, should we be concern about the banking sector? How are we hedging? @TigerStars $SPDR S&P Bank ET
4.99K
·
10-21 09:41
I opened $TRAD CHI MED(00570)$ ,Big sell off due to failed takeover deal. Still a profitable company and the large drop seems unjustified. Entered small position and collect some dividend while waiting for it to normalize over time. May take months.
TOPgood strategy, the company management really sucks, can't keep her words.
223
·
10-21 16:59
$Amplify Treatments, Testing and Advancements ETF(GERM)$ 🦠😷🦠🤒🦠🅱🆄🅻🅻🅸🆂🅷🦠🥴🦠 🦠🦠🦠 🤧 GERM’s Grand Comeback: Are You Ready for the Breakout?🤧🦠🦠🦠 Kia ora Tiger traders! It’s time to dive into one of the most contagious sectors out there, virus treatment. The GERM ETF is bubbling up and looking ready to break out of its doom loop accumulation phase! 🦠 If you’re looking for an opportunity that gives you broad exposure to the pandemic response sector, this might be your golden shot! 📈🤢🥴 😵 👀 You can see that it looks like the sector is in the late doom loop accumulation phase! 🩺🤮 Let’s break down the essentials: • Current Price: $19.16 • Support Levels: $19.08, with deeper support around $18.55 • Resistance Levels: $19.32,
TOPAccording to the information provided, here is an analysis of Amplify Treatments, Testing and Advancements ETF (GERM): Current Price: $19.16 Support Levels: $19.08, with deeper support around $18.55 Resistance Levels: $19.32, and $20.24 as the key breakout point Dividend Yield: 1.19% with consistent quarterly payouts, the latest being $0.056 per share in March 2024 Expense Ratio: GERM has a 0.68% expense ratio, which is reasonably priced for the niche biotech sector. Holdings: GERM's top holdings include Moderna. In terms of competitor ETFs, here are a few options and their analyst ratings: XBI: 5 Buy / 6 Hold / 2 Sell IBB: 4 Buy / 5 Hold / 3 Sell BBH: 6 Buy / 4 Hold / 2 Sell It's important to note that past performance is not indicative of future results. While virus-related sectors tend to perform well during pandemics, it's crucial to consider various factors before making investment decisions. Regarding GERM breaking through the $54 barrier, it's challenging to predict future price movements with certainty. It is necessary to analyze the latest market trends, news, and economic factors that could impact the sector. To prepare for the next potential pandemic and its economic impact, traders should consider the following: Stay Informed: Keep up with the latest news related to viral treatments, research, and global pandemic preparedness. Diversify: Consider investing in a diversified portfolio that includes various sectors and asset classes to mitigate specific risks. Risk Management: Have a clear risk management strategy in place, including setting stop-loss orders and monitoring market volatility. Research: Continuously research and analyze potential investment opportunities and monitor the performance of existing holdings. Consult Professionals: Consider working with a financial advisor or professional who specializes in the biotech sector to gain valuable insights and guidance. Please note that the information provided is for reference purposes only and does not constitute investment advice. Investing in biotech and pandemic-related sectors involves risks, including volatility and uncertainty. It is essential to conduct thorough research and analysis and consider your risk tolerance before making any investment decisions. Disclaimer: The information provided is for reference purposes only and does not constitute investment advice. Always do your own research and consider your risk tolerance before making investment decisions.
1.51K
·
10-21 13:45
I opened $LNK.HK 20241230 35.00 PUT$ ,DCA link reit to ride on recovery play in HK market and interest rate changes in 2025. Hope it turns out well.
LNK.HK PUT
10-21 13:25
HK20241230 35.00
| Side | Price | Realized P&L |
|---|---|---|
| Sell Open | 0.66 | -12.12% Holding |
1.89K
·
10-21 13:45
I opened $ALB.HK 20250627 70.00 PUT$ ,Getting back into BABA on a downward pressure. I would be happy to buy BABA at 70 to average down. This could be part of China’s slow but long term recovery, so don’t want to miss the action.
ALB.HK PUT
10-21 13:44
HK20250627 70.00
| Side | Price | Realized P&L |
|---|---|---|
| Sell Open | 1.30 | -9.23% Holding |
8.94K
·
10-21 01:28
$NVIDIA Corp(NVDA)$ $Apple(AAPL)$ $CME Bitcoin - main 2410(BTCmain)$ $Coinbase Global, Inc.(COIN)$ 🔺🅱️🆄🅻🅻🅸🆂🅷🔺 🎯📈🎯 Sizzling Sector Surge: What’s Fuelling the S&P 500’s 2024 Boom? 🚀💼📊 Trump’s Election Gambit: Will Financials Catch Up to Tech and Topple 2024’s S&P Giants? 📊💼🚀🎯📈🎯 Market performance by S&P 500 sector so far in 2024: 1 Technology +31.2%🟢 2 Utilities +26.2%🟢 3 Financial +24.6%🟢 4 Comm Services +22.1%🟢 5 Industrials +17.8%🟢 6 Consumer Defensive +15.2%🟢 7 Healthcare +12.3%🟢 8 Real Estate +10.4%🟢 9 Consumer Cyclical +10.4%🟢 10 Basic Materials +7.5%🟢 11 Energy +5.5%🟢 Kia ora Tiger traders! The
TOP//@Barcode: Target 🎯 $146 $NVIDIA Corp(NVDA)$
3.40K
·
10-21 16:13
I opened $STI ETF(ES3.SI)$ ,Adding some ES3 to my dividend portfolio. Stacking those dividends!
442
·
10-19
Parkway Life REIT vs. Keppel DC REIT: Which REIT is a Buy After Earnings?
I approach investment decisions with a focus on long-term value, strong fundamentals, and a clear understanding of the business model. Let's dive into the recent earnings reports of Parkway Life REIT and Keppel DC REIT to determine which one presents a better investment opportunity. Parkway Life REIT: Defensive REIT with Moderate Growth Parkway Life REIT (PLife) reported a gross revenue of S$30.6 million for the third quarter of FY2024, a decline of 2.2% year-on-year. This dip is largely attributed to the depreciation of the Japanese yen against the Singapore dollar. However, contributions from newly acquired properties in 2023 and 2024 partially offset this decline. The REIT reported a distribution per unit (DPU) of 11.3 cents for 9MFY2024. Despite the challenges, PLife remains a defensiv
378
·
10-21 01:59
$Bitfarms Ltd.(BITF)$ $CME Bitcoin - main 2410(BTCmain)$ 🔺🅱🆄🅻🅻🅸🆂🅷🔺 Target 🎯 $4 minimum $BITF 🗞️📰🚨 Source: The Kobeissi Letter: Bitcoin is back. While everyone was focused on stocks, #Bitcoin silently began a new bull market. Over the last 12 months, crypto has added $1.3 TRILLION of market cap. If Bitcoin was a company, it would be the 8th largest company in the WORLD. What happened? Bitcoin is back. While everyone was focused on stocks, #Bitcoin silently began a new bull market. Over the last 12 months, crypto has added $1.3 TRILLION of market cap. If Bitcoin was a company, it would be the 8th largest company in the WORLD. What happened? Over the last 12 months, Bitcoin is now up a whopping 142%. Si
TOPBitfarms Ltd. Stock Analysis Company Overview:Bitfarms Ltd. is a cryptocurrency mining company. They operate blockchain computing centres that power the global decentralized financial economy. Earnings and Forecast: The forecast for the fiscal year 2024 shows an expected EPS of -0.24 USD, forecast gross income of 221.78 million USD, and a forecast EBIT of -65.18 million USD. The forecast for the fiscal year 2025 shows an expected EPS of 0.02 USD, forecast gross income of 512.05 million USD, and a forecast EBIT of 54.80 million USD. Analyst Recommendation: There is one recommendation, with 5 buy and 1 hold ratings. Analyst Target Price: The mean target estimate from 8 analysts is 3.89363 USD, with a range from 2.3 USD to 5.09907 USD. Capital Flow: The capital flow data for the past 5 days shows inflows and outflows, with a total inflow of 3341.62 million USD and a total outflow of 3159.51 million USD. Support and Resistance Price: As of October 18th, the support price is at 2.0 USD, and the resistance price is at 2.06 USD. Profitability Ratio: The profit ratio as of October 18th is 0.2991. Earnings Results: The earnings report for the second quarter of 2024 showed an EPS of -0.07 USD, a return on equity of -25.35%, and a gross profit margin of -27.14%. Stock Price: As of October 21st, the stock price is 2.06 USD. Summary and Analysis:Based on the analysis, here are the key points for Bitfarms Ltd.: Bitfarms operates in the cryptocurrency mining industry, which has been experiencing growth. The company's earnings forecast shows varying results for the fiscal years 2024 and 2025. Analyst recommendations suggest a positive sentiment towards the stock, with a mean target estimate of 3.89363 USD. The capital flow data indicates recent inflows and outflows. The support and resistance prices provide important levels to watch in the stock's price movement. The profitability ratio indicates the company's ability to generate profit. The earnings results for the second quarter of 2024 show negative figures in some areas. Please note that the above information is for reference purposes only and should not be considered as investment advice. The stock market carries inherent risks, and investors should conduct their own research and analysis before making any investment decisions.
541
·
10-21 08:17
$Singtel(Z74.SI)$ https://sporeshare.blogspot.com/2024/10/singtel-she-seems-to-be-able-to-stay.html SingTel- She seems to be able to stay above tge 50 Days Moving Average, looks like market doesn't want her to go down! Lets see if she can rise up to clear 3.32 level smoothly! Beyond 3.32, she may rise up to retest the recent high of 3.41. She will be reporting her 1st Half results in November, estimating interim + special of 5.2 cents & 1.9 cents. That is 7.1 cents plus Final dividend abd special of 7.9 cents, total dividend is 15 cents. Yield is about 4.6% which is quite decent. If you want something above 5% yield can look at ComfortDelGro or Wilmar. Pls dyodd.
TOPthanks for sharing
174
·
10-21 08:31
Preview of the week starting 21Oct24 - do you need some SAP?
Public Holidays There are no public holidays in Singapore, Hong Kong, America, or Singapore in the coming week. Economic Calendar (21Oct24) Notable Highlights Existing Home Sales and New Home Sales figures will update us on the real estate market. S&P Global US manufacturing PMI was 47.3 previously. A figure of under 50 indicates a contraction. Are we able to see a rebound in the manufacturing sector? S&P Global US services PMI was 55.2 previously. This implies growth in the services sector. Will this sector continues its growth? Durable Goods Orders contracted by 0.9% previously. Investopedia defines Durable Goods as: new orders placed with domestic manufacturers for delivery of long-lasting manufactured goods (durable goods) in the near term or future. Will this be good news for
467
·
10-21 08:49
Earnings of the week (21Oct24) - should we get some SAP?
Earnings Calendar (21Oct24) Q4/2024 has started. We have some interesting earnings namely, SAP, GM, Tesla, UPS and IBM. Let us look at SAP. Observations of SAP: Revenue grew from $21.6 billion in 2014 to $34 billion in 2023. Gross profit grew from $15.5 billion in 2014 to $24.5 billion in 2023. Operating profit grew from $5.8 billion in 2014 to $6.5 billion in 2023. Earnings per share EPS grew from $3.38 in 2014 to $5.67 in 2023. The 10-year median margins for gross profit is at 70.7% and 16.1% for free cash flow (FCF). The P/E ratio stands at 94.3. The stock price grew 76% from a year ago. The Technical Analysis recommends a “STRONG BUY”. The Analysts Sentiment recommends a “BUY” rating with a price target of $242.19 that represents an upside of 5.10%. For the coming earnings, the fo
255
·
10-21 10:37
If Harris is elected president, the U.S. stock market could be under long-term pressure
Although some of Kamala Harris's policy proposals may benefit specific sectors in the U.S. stock market, such as cannabis-related stocks, overall, her economic policies are bearish for the broader U.S. stock market. Below are some of Harris’s key policy proposals, which stand in stark contrast to Donald Trump’s: 1. Raising Corporate Taxes: Harris plans to raise the U.S. corporate tax rate to 28%, which would negatively impact most publicly traded U.S. companies by reducing corporate profits, lowering the potential for dividends and stock buybacks, and decreasing valuations. 2. Promoting Antitrust Measures: Harris appears to be even tougher on antitrust issues than the current administration, or at the very least, would continue the current administration’s antitrust agenda. This would nega
169
·
10-21 11:52
Watch Verizon (VZ) ROE and Debt Relationship For Long-Term Broadband Strategy
We are expecting several Dow Jones stocks earnings in the coming week, and $Verizon(VZ)$ is scheduled to release its third-quarter earnings before market open on Tuesday (22 Oct). Investors and market will be expecting Verizon to provide an update to its long-term broadband strategy when it reports earnings, expecting to learn more about its fiber builds and also their new fixed wireless access (FWA) subscriber target. Another telecommunications name $T-Mobile US(TMUS)$ would be reporting its Q3 results after Wednesday (23 Oct) market close, both of them would lead the broadband industry each capturing 85% flow share which is mostly through the fixed wireless access (FWA) subscription. So I will be looking
TOPI think it's crucial to keep an eye on Verizon's ROE and debt-to-equity ratio.
251
·
10-21 15:39
Is Gold going to have an 'I love you 3000 moment'? Gold prices have surged to $2,700 per ounce, a milestone that signals a significant shift in global financial markets. As investors flock to safe-haven assets amidst geopolitical instability, inflationary pressures, and economic uncertainty, many are asking the critical question: could gold hit $3,000 per ounce in the near future? Why Gold is Soaring Several key factors have contributed to the recent spike in gold prices: 1. Inflation Hedge: Inflationary concerns have plagued global markets, as central banks around the world continue to grapple with rising prices. Investors often turn to gold as a hedge against inflation because of its historical stability in preserving value. With inflation continuing to outpace interest rates, the
43
·
10-19
SPX - The bullish trend is expected to persist
$.SPX(.SPX)$ $SPDR S&P 500 ETF Trust(SPY)$ The S&P 500 closed at 5,841.5 with a slight decline of -0.02%. The current market trend remains Bullish, and the recommended long-term strategy is Buy and Hold. The bullish zone offers high return potential with lower risk. The index has been in this zone for 25 days, generating a cumulative return of 4.4%.Long-term strategy: Continue holding positions as there is no significant change expected in the trend. If the market enters a bearish zone, it would signal a selling opportunity.Short-term strategy: The S&P 500 is currently experiencing a correction trend, marked by slight fluctuations and downward movements. The recommended approach is to buy durin
263
·
10-19
Quest Diagnostics Has Massive Secular Tailwind and Strong Base
2.0% Yield.Strong secular volume tailwind from aging population, with Medicare Advantage holders having a higher average revenue-per-test.AI (Artificial Intelligence) in pathology testing should drive high margin growth.Tailwind from more bespoke testing, with genetic testing seeing a market-wide spending growth of 8% and 5% volume growth according to Avalon.Increasing leverage to 2.5-3.0x debt to EBITDA to enable more freedom in aggressive acquisitions.Strong M&A profile, purchasing Canadian provider LifeLabs for $1 billion, which will generate $710 million in additional annual revenues by 2025.Investment Thesis $Quest Diagnostics(DGX)$ is a provider of medical diagnostic services to markets across the world. Operations are focused on No
Most Discussed
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email：uservice@ttm.financial